Search

Your search keyword '"De Brot, Louise"' showing total 191 results

Search Constraints

Start Over You searched for: Author "De Brot, Louise" Remove constraint Author: "De Brot, Louise"
191 results on '"De Brot, Louise"'

Search Results

1. Genomic landscapes of ovarian clear cell carcinoma from latin countries reveal aberrations linked to survival and progression

4. Clinical correlation of lymphovascular invasion and Silva pattern of invasion in early-stage endocervical adenocarcinoma: proposed binary Silva classification system

5. Horizontal tumor extent (HZTE) has limited prognostic significance in 2018 FIGO stage I endocervical adenocarcinoma (ECA): a retrospective study of 416 cases

8. Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial)

9. Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study

13. Does sentinel node mapping impact morbidity and quality of life in endometrial cancer?

14. Uterine Sarcoma With EML4::NTRK3 Fusion: A Spectrum of Mesenchymal Neoplasms Harboring Actionable Gene Fusions

17. Prognostic impact of platinum sensitivity in ovarian carcinoma patients with brain metastasis

18. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil

22. Can mismatch repair status be added to sentinel lymph node mapping algorithm in endometrioid endometrial cancer?

23. Uterine Sarcoma With EML4::NTRK3 Fusion: A Spectrum of Mesenchymal Neoplasms Harboring Actionable Gene Fusions

25. HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors

26. Genomic landscapes of ovarian clear cell carcinoma from Latin countries reveal aberrations linked to survival and progression

27. Impact of lymph node staging in presumed early-stage ovarian carcinoma

28. Reassessment of low- and intermediate-risk endometrial cancer reports by gynecological pathologists increases risk classification without impacting outcome

30. 2022-RA-998-ESGO Intermediate-risk endometrial cancer: isolated tumor cells (ITC)versusnode-negative in sentinel lymph node mapping. An international multi-institutional comparative study

31. 2022-RA-1052-ESGO Low-risk endometrial cancer and no adjuvant treatment: do isolated tumor cells (ITC) have an effect on recurrence? An international multi-institutional comparative study between ITC and node-negative in sentinel lymph node biopsy

32. 2022-RA-987-ESGO Molecular characterization of endometrial cancer with low volume metastasis in the sentinel lymph node: a multicentric international study

38. Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with SMARCB1 Mutation: A Literature Review of a Rare and Aggressive Condition

39. Horizontal tumor extent (HZTE) has limited prognostic significance in 2018 FIGO stage I endocervical adenocarcinoma (ECA): a retrospective study of 416 cases

41. Retrospective analysis of the role of cyclin E1 overexpression as a predictive marker for the efficacy of bevacizumab in platinum-sensitive recurrent ovarian cancer

43. Pathological factors associated with non‐sentinel lymph node metastasis in early stage cervical cancer

44. FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers

47. Should we wait 3 months for a repeat aspiration in non‐diagnostic/indeterminate thyroid nodules? A cancer centre experience

48. An Isothermal, Multiplex Amplification Assay for Detection and Genotyping of Human Papillomaviruses in Formalin-Fixed, Paraffin-Embedded Tissues

Catalog

Books, media, physical & digital resources